Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Infinity Pharmaceuticals, Inc. (INFI)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
0.5489+0.0089 (+1.65%)
At close: 04:00PM EST
0.5321 -0.02 (-3.06%)
After hours: 04:53PM EST
Advertisement
Advertisement
Show:
Annual
Subscribe to Yahoo Finance Plus Essential to download historical data

Income Statement

All numbers in thousands
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.
Breakdown
ttm
12/31/2021
12/31/2020
12/31/2019
12/31/2018
Total Revenue
2,501
1,858
1,719
3,049
22,146
Cost of Revenue
1,508
1,120
1,037
7,308
69
Gross Profit
993
738
682
-4,259
22,077
Operating Expense
47,799
45,821
39,179
41,405
34,006
Operating Income
-46,806
-45,083
-38,497
-45,664
-11,929
Net Non Operating Interest Income Expense
-180
-180
-2,445
-2,563
-93
Other Income Expense
196
1
450
1,116
769
Pretax Income
-46,790
-45,262
-40,492
-47,111
-11,253
Tax Provision
-
-
0
-54
0
Net Income Common Stockholders
-46,790
-45,262
-40,492
-47,057
-11,253
Diluted NI Available to Com Stockholders
-46,790
-45,262
-40,492
-47,057
-11,253
Basic EPS
-
-0.53
-0.68
-0.83
-0.20
Diluted EPS
-
-0.53
-0.68
-0.83
-0.20
Basic Average Shares
-
85,597
59,858
56,984
55,411
Diluted Average Shares
-
85,597
59,858
56,984
55,411
Total Operating Income as Reported
-46,806
-45,083
-38,497
-45,664
-11,929
Total Expenses
49,307
46,941
40,216
48,713
34,075
Net Income from Continuing & Discontinued Operation
-46,790
-45,262
-40,492
-47,057
-11,253
Normalized Income
-46,986
-45,263
-40,942
-48,172
-12,022
Interest Expense
180
180
2,445
2,563
93
Net Interest Income
-180
-180
-2,445
-2,563
-93
EBIT
-46,610
-45,082
-38,047
-44,548
-11,160
EBITDA
-46,138
-
-
-
-
Reconciled Cost of Revenue
1,508
1,120
1,037
7,308
69
Reconciled Depreciation
472
480
483
219
191
Net Income from Continuing Operation Net Minority Interest
-46,790
-45,262
-40,492
-47,057
-11,253
Total Unusual Items Excluding Goodwill
196
1
450
1,116
769
Total Unusual Items
196
1
450
1,116
769
Normalized EBITDA
-46,334
-44,603
-38,014
-45,445
-11,738
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
1.2792
0
Advertisement
Advertisement